SCHEMBL8048508

SCHEMBL8048508

[CH2]C(NP(=O)(O)Cc1ccccc1)c1c[nH]c2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.43
FFAR1 O14842 2/20 0.42
MGAM O43451 5/20 0.41
GAA P10253 5/20 0.41
SI P14410 5/20 0.41
MGAM2 Q2M2H8 5/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
MAPT P10636 2/20 0.41
PKM P14618 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7612711 0.84 MAPT (0.46) GPR84FFAR1MGAMGAASI
SCHEMBL5057941 0.80 HDAC3 (0.47) GPR84FFAR1MGAMGAASI
SCHEMBL5057888 0.78 ACE (0.47) MEN1KMT2AMAPTPKMHTR2A
SCHEMBL8425814 0.78 ACP3 (0.53) GAACMA1
SCHEMBL7608831 0.78 GPR84 (0.43) GPR84FFAR1MGAMGAASI
SCHEMBL5054823 0.75 ACE (0.58) MAPTL3MBTL1
SCHEMBL7607687 0.73 HPGDS (0.43) MEN1KMT2AMAPTPKM
SCHEMBL5057944 0.73 KMT2A (0.53) MEN1KMT2AMAPTSLC6A2FNTA
SCHEMBL7606496 0.72 MAPT (0.56) GPR84FFAR1MGAMGAASI
SCHEMBL7609471 0.72 MAPT (0.46) GPR84FFAR1MGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005348-A1 NAALADASE COMPOSITIONS AND METHODS FOR TREATING GLUTAMATE ABNORMALITY AND EFFECTING NEURONAL ACTIVITY IN ANIMALS GUILFORD PHARMACEUTICALS INC. (US) 2000-06-07 EP disclosed
WO-1998013046-A1 NAALADASE COMPOSITIONS AND METHODS FOR TREATING GLUTAMATE ABNORMALITY AND EFFECTING NEURONAL ACTIVITY IN ANIMALS GUILFORD PHARMACEUTICALS INC. (US) 1998-04-02 WO disclosed